A Study on Adherence to Therapeutic Regimen in, Disease Control and :@0.108922:0.052234:0.954920:0.052234:0.954920:0.032312:0.108922:0.032312:0.017521:0.006209:0.014676:0.010348:0.015052:0.015663:0.013876:0.006209:0.015264:0.015028:0.006209:0.017213:0.015663:0.015028:0.014534:0.009666:0.014534:0.015028:0.013688:0.014534:0.006209:0.010205:0.015264:0.006209:0.014182:0.015028:0.014534:0.009549:0.013970:0.015663:0.014534:0.015052:0.010348:0.006867:0.013688:0.006209:0.017098:0.014534:0.015687:0.006867:0.023119:0.014534:0.015028:0.006209:0.006867:0.015028:0.006985:0.006209:0.017942:0.006867:0.012230:0.014534:0.013970:0.012230:0.014534:0.006209:0.016719:0.015264:0.014840:0.010348:0.009478:0.015264:0.006867:0.006209:0.013970:0.015028:0.015663:0.006209
the related Factors Among Type 2 Diabetes Omani Patients in Dhofar.:@0.115907:0.072189:0.941724:0.072189:0.941724:0.052267:0.115907:0.052267:0.010348:0.015028:0.014534:0.006209:0.009666:0.014534:0.006867:0.013827:0.010348:0.014534:0.015663:0.006209:0.014041:0.013970:0.013688:0.010207:0.015264:0.009572:0.012230:0.006209:0.017521:0.023119:0.015264:0.015028:0.015687:0.006209:0.012745:0.013876:0.015663:0.014534:0.006209:0.014229:0.006209:0.017942:0.006867:0.013970:0.015663:0.014393:0.010348:0.014534:0.012230:0.006209:0.019426:0.023119:0.013970:0.015028:0.006867:0.006209:0.015708:0.013829:0.010348:0.006867:0.014534:0.014840:0.010348:0.012230:0.006209:0.006867:0.015028:0.006209:0.017942:0.015028:0.015052:0.009313:0.013970:0.008702:0.006773
Dr. Jayasree . R  and Mr. Zakir Hussain:@0.356579:0.109224:0.694942:0.109224:0.694942:0.088394:0.356579:0.088394:0.016051:0.006726:0.004979:0.004957:0.006573:0.009194:0.010024:0.009522:0.008015:0.007818:0.009388:0.009281:0.004957:0.004979:0.004957:0.013562:0.004957:0.004957:0.009391:0.011858:0.011531:0.004957:0.019305:0.006726:0.004979:0.004957:0.013584:0.009694:0.010919:0.005853:0.008102:0.004957:0.015877:0.011531:0.007906:0.008146:0.009391:0.005853:0.011946
1:@0.694941:0.101764:0.701053:0.101764:0.701053:0.089620:0.694941:0.089620:0.006111
Ahmed Nasser, Alya Musallam, Khadijah Abdul Rub, Maha Saleem, Muna Bakhit, May Salim,:@0.156807:0.144914:0.900828:0.144914:0.900828:0.123875:0.156807:0.123875:0.013792:0.010612:0.016197:0.008543:0.010493:0.004511:0.014249:0.008667:0.007194:0.007450:0.008446:0.006121:0.004531:0.004511:0.013792:0.004889:0.009122:0.008724:0.004511:0.017051:0.010493:0.007413:0.008822:0.005127:0.005088:0.008545:0.016276:0.004531:0.004511:0.013534:0.010553:0.008724:0.010493:0.005088:0.005147:0.008822:0.010612:0.004511:0.013136:0.010274:0.010255:0.010652:0.005028:0.004511:0.011924:0.010471:0.009521:0.004531:0.004511:0.017369:0.008824:0.010553:0.008724:0.004511:0.009420:0.008824:0.005028:0.008543:0.008446:0.016276:0.004531:0.004511:0.017051:0.010553:0.010811:0.008724:0.004511:0.011864:0.008824:0.010034:0.010612:0.005088:0.006061:0.004531:0.004511:0.017369:0.008367:0.009122:0.004511:0.009420:0.008824:0.005028:0.005326:0.016276:0.004531
Salim Rajab, Shareefa Said, Shima Rashid:@0.362673:0.163442:0.689409:0.163442:0.689409:0.142403:0.362673:0.142403:0.009420:0.008824:0.005028:0.005326:0.016276:0.004511:0.012699:0.008347:0.005147:0.008565:0.009519:0.004531:0.004511:0.009301:0.010553:0.008545:0.007115:0.008545:0.008446:0.005882:0.008724:0.004511:0.009420:0.008547:0.005326:0.010374:0.004531:0.004511:0.009301:0.010612:0.005326:0.016217:0.008724:0.004511:0.012699:0.008665:0.007214:0.010612:0.005326:0.010493
2:@0.689400:0.155909:0.694961:0.155909:0.694961:0.143643:0.689400:0.143643:0.005561
1. Tutor & Assistant Tutor OCHS – Dhofar   2. Bachelor of Science in Nursing 2019 – OCHS – Dhofar:@0.153757:0.198167:0.903877:0.198167:0.903877:0.180541:0.153757:0.180541:0.008870:0.004213:0.004195:0.009609:0.009591:0.005525:0.009202:0.006856:0.004195:0.013138:0.004195:0.012473:0.006689:0.006782:0.004895:0.006689:0.005747:0.007946:0.009757:0.005636:0.004195:0.009609:0.009591:0.005525:0.009202:0.006856:0.004195:0.014136:0.012288:0.014155:0.008759:0.004195:0.009609:0.004195:0.013506:0.009794:0.009202:0.005470:0.007946:0.006856:0.004195:0.004195:0.004195:0.008870:0.004213:0.004195:0.011030:0.008112:0.007706:0.009794:0.007780:0.004675:0.009202:0.006856:0.004195:0.009202:0.005470:0.004195:0.009018:0.007817:0.004952:0.007853:0.010034:0.007817:0.007853:0.004195:0.004952:0.010108:0.004195:0.013083:0.009812:0.006743:0.006782:0.004952:0.009960:0.008648:0.004195:0.008870:0.008870:0.008870:0.008870:0.004195:0.009609:0.004195:0.014134:0.012288:0.014155:0.008759:0.004195:0.009609:0.004195:0.013508:0.009794:0.009202:0.005470:0.007946:0.006856
Problem Statement::@0.070000:0.268764:0.276504:0.268764:0.276504:0.251688:0.070000:0.251688:0.013647:0.008124:0.013083:0.013426:0.005886:0.012458:0.019816:0.005322:0.012577:0.008870:0.011853:0.008870:0.012458:0.019816:0.012458:0.012720:0.008870:0.006249
Diabetes can strike anyone from any walk of life. In the last decade the cases of people living with diabetes :@0.070000:0.306393:0.934850:0.306393:0.934850:0.285563:0.070000:0.285563:0.015615:0.005481:0.008976:0.010854:0.008845:0.006093:0.008845:0.007578:0.003822:0.008866:0.008954:0.011509:0.003822:0.007469:0.006333:0.007796:0.005525:0.010199:0.008845:0.003822:0.008954:0.011007:0.009412:0.010439:0.011422:0.008845:0.003822:0.006246:0.007381:0.010439:0.017449:0.003822:0.008954:0.011007:0.009587:0.003822:0.014523:0.009260:0.005195:0.010395:0.003822:0.010439:0.006027:0.003822:0.005088:0.005416:0.005831:0.008714:0.004542:0.003822:0.006661:0.011509:0.003822:0.006355:0.011138:0.008845:0.003822:0.005154:0.009085:0.007469:0.006224:0.003822:0.011094:0.008952:0.008866:0.009150:0.011094:0.008845:0.003822:0.006355:0.011138:0.008845:0.003822:0.008866:0.009085:0.007753:0.008845:0.007578:0.003822:0.010441:0.006027:0.003822:0.011203:0.008954:0.010461:0.010854:0.005088:0.008845:0.003822:0.005088:0.005263:0.009740:0.005416:0.011334:0.009784:0.003822:0.014586:0.005156:0.006355:0.011225:0.003822:0.011094:0.005481:0.008976:0.010854:0.008845:0.006093:0.008845:0.008015:0.004957
jumped almost 50% worldwide. It Type 2 DM affects more than 422 million people worldwide and there :@0.070000:0.324923:0.934962:0.324923:0.934962:0.304093:0.070000:0.304093:0.004936:0.011160:0.017034:0.011203:0.008954:0.011094:0.004346:0.009260:0.005088:0.017360:0.010701:0.007471:0.006224:0.004346:0.010046:0.010046:0.016073:0.004346:0.014348:0.010439:0.007578:0.005088:0.010941:0.014588:0.005416:0.011094:0.008714:0.004542:0.004346:0.006158:0.006224:0.004346:0.011443:0.009587:0.011203:0.008845:0.004346:0.010046:0.004346:0.015287:0.019021:0.004346:0.008956:0.006126:0.005492:0.008954:0.008952:0.006224:0.007578:0.004346:0.017362:0.010439:0.007381:0.008845:0.004346:0.006355:0.011160:0.008954:0.011509:0.004346:0.010046:0.010046:0.010046:0.004346:0.017449:0.005525:0.005198:0.005088:0.005416:0.010439:0.011509:0.004346:0.011203:0.008952:0.010463:0.010854:0.005088:0.008845:0.004346:0.014348:0.010439:0.007578:0.005088:0.010941:0.014588:0.005416:0.011094:0.008845:0.004346:0.008954:0.011422:0.011094:0.004346:0.006355:0.011138:0.008845:0.007381:0.009281:0.004957
will be an estimated 35000 people with type 2 DM living in Oman by 2050. Living with type 2 DM places an :@0.070000:0.343453:0.934964:0.343453:0.934964:0.322622:0.070000:0.322622:0.014588:0.005525:0.005198:0.005088:0.002959:0.010852:0.008845:0.002959:0.008954:0.011509:0.002959:0.008845:0.007469:0.006333:0.005416:0.017384:0.008735:0.006093:0.008954:0.011094:0.002959:0.010046:0.010046:0.010046:0.010046:0.010046:0.002959:0.011203:0.008954:0.010461:0.010854:0.005088:0.008845:0.002959:0.014588:0.005154:0.006355:0.011225:0.002957:0.006290:0.009587:0.011203:0.008845:0.002959:0.010046:0.002959:0.015287:0.019021:0.002959:0.005088:0.005263:0.009740:0.005416:0.011334:0.009784:0.002959:0.005416:0.011509:0.002959:0.015877:0.017384:0.008954:0.011509:0.002959:0.010308:0.009587:0.002959:0.010046:0.010046:0.010046:0.010046:0.004542:0.002959:0.011443:0.005263:0.009740:0.005416:0.011334:0.009784:0.002959:0.014588:0.005154:0.006355:0.011225:0.002959:0.006287:0.009587:0.011201:0.008845:0.002959:0.010046:0.002959:0.015287:0.019021:0.002959:0.010854:0.005154:0.009150:0.008801:0.008845:0.007578:0.002959:0.008954:0.011946:0.004957
enormous physical, emotional and financial burden on the family. Diabetes and its complications remain :@0.070000:0.361983:0.934877:0.361983:0.934877:0.341152:0.070000:0.341152:0.008845:0.011422:0.010439:0.007796:0.017362:0.010461:0.011094:0.007578:0.004018:0.010854:0.010723:0.009587:0.007578:0.005416:0.008866:0.009260:0.004957:0.004542:0.004018:0.008845:0.017362:0.010461:0.006333:0.005416:0.010439:0.011443:0.009260:0.005088:0.004018:0.008954:0.011424:0.011094:0.004018:0.005842:0.005405:0.011443:0.008954:0.011422:0.008801:0.005481:0.009260:0.005088:0.004018:0.010417:0.011160:0.007381:0.011094:0.008845:0.011509:0.004018:0.010439:0.011509:0.004018:0.006355:0.011138:0.008845:0.004018:0.006027:0.008954:0.017449:0.005525:0.004936:0.007993:0.004542:0.004018:0.015615:0.005481:0.008976:0.010854:0.008845:0.006093:0.008845:0.007578:0.004018:0.008954:0.011422:0.011094:0.004018:0.005154:0.006224:0.007578:0.004018:0.008801:0.010439:0.017034:0.010854:0.005088:0.005416:0.008866:0.008735:0.006333:0.005416:0.010439:0.011334:0.007578:0.004018:0.007381:0.008845:0.017384:0.008954:0.005416:0.011946:0.004957
major causes of morbidity and mortality, as it is a progressive disease, compliance to the treatment is essential :@0.070000:0.380512:0.934938:0.380512:0.934938:0.359682:0.070000:0.359682:0.017384:0.008735:0.005263:0.010439:0.007665:0.002075:0.008866:0.008735:0.011094:0.007753:0.008845:0.007578:0.002075:0.010439:0.006027:0.002075:0.017362:0.010439:0.007665:0.010395:0.005416:0.011094:0.005154:0.006290:0.009587:0.002075:0.008954:0.011422:0.011094:0.002075:0.017362:0.010439:0.007884:0.006355:0.009260:0.005088:0.005154:0.006290:0.007993:0.004542:0.002075:0.009087:0.007578:0.002075:0.005154:0.006224:0.002075:0.005350:0.007578:0.002075:0.009150:0.002075:0.010745:0.007381:0.010701:0.009893:0.007381:0.008845:0.007469:0.007578:0.005263:0.009500:0.008845:0.002075:0.011094:0.005350:0.007753:0.008976:0.009085:0.007753:0.008714:0.004542:0.002075:0.008801:0.010439:0.017034:0.010854:0.005088:0.005481:0.008954:0.011422:0.008801:0.008845:0.002075:0.006093:0.010701:0.002075:0.006355:0.011138:0.008845:0.002075:0.006333:0.007381:0.008973:0.008738:0.006331:0.017362:0.008845:0.011094:0.006224:0.002075:0.005350:0.007578:0.002075:0.008845:0.007469:0.007753:0.008845:0.011094:0.006333:0.005481:0.009257:0.005525:0.004957
to maintain glycemic control and prevention of complication, thereby increase level of disease controlling, :@0.070000:0.399042:0.934968:0.399042:0.934968:0.378212:0.070000:0.378212:0.006093:0.010701:0.003374:0.017384:0.008954:0.005416:0.011094:0.006355:0.008954:0.005416:0.011509:0.003374:0.009937:0.004936:0.009412:0.008801:0.008845:0.017449:0.005416:0.008801:0.003372:0.008801:0.010439:0.011094:0.006333:0.007381:0.010550:0.005088:0.003372:0.008956:0.011422:0.011094:0.003374:0.010745:0.007381:0.009017:0.009502:0.008845:0.011094:0.006333:0.005416:0.010439:0.011509:0.003374:0.010439:0.006027:0.003374:0.008801:0.010439:0.017034:0.010854:0.005088:0.005416:0.008866:0.008735:0.006333:0.005416:0.010439:0.011509:0.004542:0.003374:0.006355:0.011138:0.008845:0.007381:0.008779:0.010308:0.009587:0.003374:0.005416:0.011422:0.008801:0.007381:0.008976:0.009085:0.007753:0.008845:0.003372:0.005088:0.009019:0.009500:0.008757:0.005088:0.003374:0.010439:0.006027:0.003374:0.011094:0.005350:0.007753:0.008976:0.009085:0.007753:0.008845:0.003374:0.008801:0.010439:0.011094:0.006333:0.007381:0.010548:0.005198:0.005088:0.005416:0.011334:0.009847:0.004979:0.004957
but poor adherence to medications is known to be common in Type 2DM patients with adherence rate :@0.070000:0.417572:0.934964:0.417572:0.934964:0.396741:0.070000:0.396741:0.010417:0.010897:0.006224:0.005132:0.011203:0.010897:0.010439:0.007665:0.005132:0.009150:0.011203:0.011138:0.008845:0.007381:0.008845:0.011422:0.008801:0.008845:0.005132:0.006093:0.010701:0.005132:0.017362:0.008952:0.011094:0.005416:0.008866:0.008735:0.006333:0.005416:0.010439:0.011334:0.007578:0.005132:0.005353:0.007578:0.005132:0.010483:0.011422:0.010352:0.014588:0.011509:0.005132:0.006093:0.010701:0.005132:0.010854:0.008845:0.005132:0.008801:0.010439:0.017449:0.017362:0.010439:0.011509:0.005132:0.005416:0.011509:0.005132:0.011443:0.009587:0.011203:0.008845:0.005132:0.010046:0.015287:0.019021:0.005132:0.011116:0.008735:0.006333:0.005416:0.008845:0.011096:0.006224:0.007578:0.005132:0.014588:0.005154:0.006355:0.011225:0.005132:0.009150:0.011203:0.011138:0.008845:0.007381:0.008845:0.011422:0.008801:0.008845:0.005132:0.007665:0.008735:0.006093:0.009281:0.004957
varying from 30 -90%. It significantly undermines the effectiveness of treatment and represent an import-:@0.070000:0.436102:0.929897:0.436102:0.929897:0.415271:0.070000:0.415271:0.009675:0.008954:0.008299:0.009653:0.005416:0.011334:0.009784:0.003582:0.006246:0.007381:0.010439:0.017449:0.003582:0.010046:0.010046:0.003582:0.007338:0.010046:0.010046:0.016073:0.004542:0.003582:0.006158:0.006224:0.003582:0.007578:0.005416:0.009893:0.011509:0.005416:0.005842:0.005405:0.008866:0.008954:0.011094:0.006355:0.004936:0.009587:0.003582:0.011160:0.011422:0.011094:0.008845:0.007796:0.017449:0.005416:0.011419:0.008845:0.007578:0.003582:0.006355:0.011138:0.008845:0.003582:0.008845:0.006126:0.005492:0.008954:0.008954:0.006333:0.005263:0.009500:0.008845:0.011424:0.008845:0.007471:0.007578:0.003582:0.010439:0.006027:0.003582:0.006333:0.007381:0.008976:0.008735:0.006333:0.017362:0.008845:0.011094:0.006224:0.003582:0.008954:0.011422:0.011094:0.003582:0.007381:0.008845:0.010745:0.007381:0.008845:0.007753:0.008845:0.011094:0.006224:0.003582:0.008954:0.011509:0.003582:0.005416:0.017034:0.011203:0.010439:0.007884:0.006224:0.007775
ant issue in disease control. (Sabate E, 2003). The aim of this study was to describe adherence to therapeutic :@0.070000:0.454631:0.934890:0.454631:0.934890:0.433801:0.070000:0.433801:0.008954:0.011094:0.006224:0.003036:0.005350:0.007469:0.007469:0.011160:0.008845:0.003036:0.005416:0.011509:0.003036:0.011094:0.005350:0.007751:0.008976:0.009085:0.007753:0.008845:0.003036:0.008801:0.010439:0.011094:0.006333:0.007381:0.010548:0.004957:0.004542:0.003036:0.007119:0.009915:0.008976:0.010766:0.008735:0.006093:0.008845:0.003036:0.011968:0.004542:0.003036:0.010046:0.010046:0.010046:0.010046:0.007119:0.004542:0.003036:0.011695:0.011170:0.008845:0.003036:0.008954:0.005416:0.017449:0.003036:0.010439:0.006027:0.003036:0.006355:0.011225:0.005350:0.007578:0.003036:0.007467:0.006008:0.011160:0.010941:0.009587:0.003036:0.014523:0.009085:0.007578:0.003036:0.006093:0.010701:0.003036:0.011094:0.008845:0.007753:0.008801:0.007796:0.005329:0.010854:0.008845:0.003036:0.009150:0.011201:0.011138:0.008845:0.007381:0.008845:0.011422:0.008801:0.008845:0.003036:0.006093:0.010701:0.003036:0.006355:0.011138:0.008845:0.007665:0.008735:0.011201:0.008845:0.010897:0.006333:0.005416:0.009238:0.004957
regimen in, disease control and the related factors Among Type 2 diabetes Omani patients in Dhofar. H1: :@0.070000:0.473161:0.934894:0.473161:0.934894:0.452331:0.070000:0.452331:0.007381:0.008845:0.009893:0.005416:0.017362:0.008845:0.011509:0.003931:0.005416:0.011509:0.004542:0.003931:0.011094:0.005350:0.007753:0.008973:0.009087:0.007753:0.008845:0.003931:0.008801:0.010437:0.011096:0.006331:0.007381:0.010550:0.005088:0.003931:0.008954:0.011422:0.011094:0.003931:0.006355:0.011138:0.008845:0.003931:0.007381:0.008757:0.005154:0.008735:0.006093:0.008954:0.011094:0.003931:0.006027:0.009150:0.008952:0.006093:0.010439:0.007534:0.007578:0.003931:0.014590:0.017360:0.010441:0.011334:0.009784:0.003931:0.011443:0.009587:0.011201:0.008845:0.003931:0.010046:0.003931:0.011094:0.005481:0.008976:0.010854:0.008845:0.006093:0.008845:0.007578:0.003931:0.015877:0.017384:0.008954:0.011509:0.005416:0.003931:0.011116:0.008735:0.006333:0.005416:0.008845:0.011094:0.006224:0.007578:0.003931:0.005416:0.011509:0.003931:0.015527:0.011138:0.010439:0.006027:0.008954:0.006290:0.004542:0.003931:0.016292:0.010046:0.004979:0.004957
There is a statistically significant prediction of level of adherence to therapeutic regimen by demographic :@0.070000:0.491691:0.934933:0.491691:0.934933:0.470860:0.070000:0.470860:0.011695:0.011170:0.008845:0.007381:0.008845:0.004215:0.005350:0.007578:0.004215:0.009150:0.004215:0.007469:0.006355:0.008733:0.006333:0.005350:0.007469:0.006333:0.005416:0.008866:0.009260:0.005198:0.004936:0.009587:0.004215:0.007578:0.005416:0.009893:0.011509:0.005416:0.005842:0.005405:0.008866:0.008954:0.011094:0.006224:0.004215:0.010745:0.007381:0.008954:0.011094:0.005416:0.008952:0.006333:0.005416:0.010439:0.011509:0.004215:0.010439:0.006027:0.004215:0.005088:0.009019:0.009500:0.008757:0.005088:0.004215:0.010439:0.006027:0.004215:0.009150:0.011203:0.011138:0.008845:0.007381:0.008845:0.011422:0.008801:0.008845:0.004215:0.006093:0.010701:0.004215:0.006355:0.011138:0.008845:0.007665:0.008735:0.011203:0.008845:0.010897:0.006333:0.005416:0.008801:0.004215:0.007381:0.008845:0.009893:0.005416:0.017362:0.008845:0.011509:0.004215:0.010308:0.009587:0.004215:0.011094:0.008845:0.017362:0.010701:0.009891:0.007665:0.008735:0.010854:0.011225:0.005416:0.009238:0.004957
factors and disease profile of the typ2 diabetic Omani patients. H2: There is a statistically significant pre-:@0.070000:0.510221:0.929978:0.510221:0.929978:0.489390:0.070000:0.489390:0.006027:0.009150:0.008954:0.006093:0.010439:0.007534:0.007578:0.004521:0.008954:0.011422:0.011094:0.004521:0.011094:0.005350:0.007753:0.008976:0.009085:0.007753:0.008845:0.004521:0.010742:0.007381:0.010441:0.005842:0.005512:0.005088:0.008845:0.004521:0.010439:0.006027:0.004521:0.006355:0.011138:0.008845:0.004521:0.006290:0.009587:0.011007:0.010046:0.004521:0.011094:0.005481:0.008976:0.010854:0.008845:0.006331:0.005416:0.008801:0.004521:0.015877:0.017384:0.008954:0.011509:0.005416:0.004521:0.011116:0.008735:0.006333:0.005416:0.008845:0.011094:0.006224:0.007578:0.004542:0.004521:0.016292:0.010046:0.004542:0.004521:0.011695:0.011170:0.008845:0.007381:0.008845:0.004521:0.005350:0.007578:0.004521:0.009150:0.004521:0.007469:0.006355:0.008738:0.006331:0.005350:0.007469:0.006333:0.005416:0.008866:0.009260:0.005198:0.004936:0.009587:0.004521:0.007578:0.005416:0.009893:0.011509:0.005416:0.005842:0.005405:0.008866:0.008956:0.011092:0.006224:0.004521:0.010745:0.007381:0.008845:0.007775
diction of disease control by demographic factors and disease profile of the typ2 diabetic :@0.070000:0.528750:0.806420:0.528750:0.806420:0.507920:0.070000:0.507920:0.011094:0.005416:0.008954:0.006333:0.005416:0.010439:0.011509:0.004717:0.010439:0.006027:0.004717:0.011094:0.005350:0.007753:0.008976:0.009085:0.007753:0.008845:0.004717:0.008801:0.010439:0.011094:0.006331:0.007381:0.010550:0.005088:0.004717:0.010308:0.009587:0.004717:0.011094:0.008845:0.017362:0.010701:0.009893:0.007665:0.008735:0.010854:0.011225:0.005416:0.008801:0.004717:0.006027:0.009150:0.008954:0.006093:0.010439:0.007534:0.007578:0.004717:0.008954:0.011422:0.011094:0.004717:0.011094:0.005350:0.007753:0.008976:0.009085:0.007753:0.008845:0.004717:0.010745:0.007381:0.010439:0.005842:0.005514:0.005088:0.008845:0.004717:0.010439:0.006027:0.004717:0.006355:0.011138:0.008845:0.004717:0.006290:0.009587:0.011007:0.010046:0.004717:0.011094:0.005481:0.008976:0.010854:0.008845:0.006333:0.005416:0.008801:0.004957
Omani patients.:@0.806148:0.528323:0.930003:0.528323:0.930003:0.509095:0.806148:0.509095:0.014655:0.016046:0.008265:0.010624:0.004999:0.004354:0.010261:0.008063:0.005846:0.004999:0.008164:0.010241:0.005745:0.006995:0.004596
Methods & Results :@0.069992:0.560964:0.266116:0.560964:0.266116:0.543888:0.069992:0.543888:0.019231:0.012337:0.008870:0.012881:0.013083:0.013426:0.010483:0.005322:0.014111:0.005322:0.014655:0.012458:0.010483:0.012902:0.005886:0.008870:0.010483:0.005322
Population: The population of present study comprised of Omani patient with Type 2 Diabetic Mellitus. :@0.070000:0.598593:0.935084:0.598593:0.935084:0.577763:0.070000:0.577763:0.010941:0.010242:0.010548:0.011050:0.004933:0.008517:0.006115:0.005198:0.010220:0.011291:0.004324:0.006071:0.011695:0.010952:0.008626:0.006071:0.010985:0.010242:0.010548:0.011050:0.004936:0.008515:0.006115:0.005198:0.010220:0.011291:0.006071:0.010220:0.005809:0.006071:0.010526:0.007163:0.008626:0.007534:0.008626:0.010876:0.006006:0.006071:0.007250:0.005787:0.010941:0.010725:0.009369:0.006071:0.008583:0.010220:0.016816:0.010526:0.007578:0.005132:0.007534:0.008735:0.010876:0.006071:0.010220:0.005809:0.006071:0.015658:0.017165:0.008735:0.011291:0.005198:0.006071:0.010897:0.008517:0.006115:0.005198:0.008626:0.010876:0.006006:0.006071:0.014370:0.004936:0.006134:0.011007:0.006071:0.011225:0.009369:0.010985:0.008626:0.006071:0.009827:0.006071:0.015396:0.005263:0.008757:0.010633:0.008626:0.006115:0.005198:0.008583:0.006071:0.018235:0.008539:0.004979:0.004870:0.004936:0.005787:0.010876:0.007360:0.004977:0.004957
Respondents: Our study respondents were Omani patients with type 2 diabetes mellitus who have registered :@0.070000:0.617123:0.935036:0.617123:0.935036:0.596292:0.070000:0.596292:0.012972:0.008626:0.007250:0.010983:0.010220:0.011203:0.010876:0.008626:0.010876:0.006006:0.007360:0.004324:0.003451:0.015767:0.010941:0.007447:0.003451:0.007250:0.005787:0.010941:0.010723:0.009369:0.003451:0.007163:0.008626:0.007250:0.010983:0.010220:0.011203:0.010876:0.008626:0.010876:0.006006:0.007360:0.003451:0.014130:0.008626:0.007163:0.008626:0.003451:0.015658:0.017163:0.008738:0.011291:0.005198:0.003451:0.010897:0.008515:0.006115:0.005198:0.008626:0.010876:0.006006:0.007360:0.003451:0.014370:0.004936:0.006137:0.011007:0.003451:0.006071:0.009369:0.010985:0.008626:0.003451:0.009827:0.003451:0.010876:0.005261:0.008757:0.010635:0.008626:0.005875:0.008626:0.007360:0.003451:0.017143:0.008539:0.004979:0.004870:0.004936:0.005787:0.010873:0.007360:0.003451:0.014457:0.010919:0.010483:0.003451:0.010941:0.008539:0.009281:0.008626:0.003451:0.007161:0.008626:0.009675:0.005132:0.007250:0.005875:0.008626:0.007163:0.008735:0.011531:0.004957
under the poly clinic A of Sultan Qaboos hospital, Salalah. Poly clinic A has diabetic department to monitor, :@0.070000:0.635653:0.934964:0.635653:0.934964:0.614822:0.070000:0.614822:0.010941:0.011203:0.010876:0.008626:0.007447:0.003721:0.006137:0.010919:0.008626:0.003721:0.010985:0.010330:0.004717:0.009369:0.003721:0.008452:0.004870:0.005198:0.011291:0.005198:0.008583:0.003721:0.014435:0.003721:0.010220:0.005809:0.003721:0.009391:0.011050:0.004608:0.006137:0.008735:0.011291:0.003723:0.015743:0.008757:0.010635:0.010679:0.010483:0.007360:0.003721:0.010919:0.010483:0.007250:0.010526:0.004936:0.006137:0.009041:0.004739:0.004324:0.003721:0.009696:0.009041:0.004933:0.009041:0.004936:0.009041:0.011007:0.004324:0.003721:0.010941:0.010330:0.004717:0.009369:0.003723:0.008452:0.004870:0.005198:0.011291:0.005198:0.008583:0.003721:0.014435:0.003723:0.010941:0.008866:0.007360:0.003721:0.010876:0.005263:0.008757:0.010635:0.008626:0.006115:0.005198:0.008583:0.003721:0.010876:0.008626:0.010897:0.008735:0.007665:0.006115:0.017143:0.008626:0.010876:0.006006:0.003723:0.005875:0.010483:0.003723:0.017143:0.010220:0.011291:0.004936:0.005875:0.010220:0.006069:0.004981:0.004957
manage and treat patients with diabetic mellitus.Sample and Sampling Procedure: A convenience sample of :@0.070000:0.654182:0.934997:0.654182:0.934997:0.633352:0.070000:0.633352:0.017165:0.008735:0.011225:0.008823:0.009391:0.008626:0.003953:0.008735:0.011203:0.010876:0.003953:0.006115:0.007163:0.008757:0.008517:0.006006:0.003953:0.010897:0.008515:0.006115:0.005198:0.008626:0.010876:0.006006:0.007360:0.003953:0.014368:0.004936:0.006137:0.011007:0.003953:0.010876:0.005263:0.008757:0.010635:0.008626:0.006113:0.005198:0.008583:0.003953:0.017143:0.008539:0.004977:0.004870:0.004936:0.005787:0.010876:0.007360:0.004324:0.009696:0.008735:0.016816:0.010635:0.004870:0.008626:0.003953:0.008738:0.011201:0.010876:0.003953:0.009696:0.008735:0.016816:0.010635:0.004870:0.005198:0.011116:0.009565:0.003953:0.011446:0.007163:0.010677:0.008583:0.008735:0.010614:0.010941:0.007163:0.008626:0.004324:0.003953:0.014435:0.003953:0.008583:0.010220:0.010788:0.009281:0.008626:0.011291:0.005198:0.008626:0.011203:0.008583:0.008626:0.003953:0.007491:0.008735:0.016816:0.010635:0.004870:0.008626:0.003953:0.010220:0.006464:0.004957
100 Omani T2DM patients who fulfilled the inclusion and exclusion criteria as given below were included in :@0.070000:0.672712:0.934999:0.672712:0.934999:0.651882:0.070000:0.651882:0.009827:0.009827:0.009827:0.003407:0.015658:0.017165:0.008735:0.011291:0.005198:0.003407:0.012819:0.009827:0.015066:0.018803:0.003407:0.010897:0.008517:0.006115:0.005198:0.008626:0.010873:0.006006:0.007360:0.003407:0.014457:0.010919:0.010483:0.003407:0.005940:0.011050:0.004870:0.005842:0.005294:0.004979:0.004870:0.008735:0.010876:0.003407:0.006137:0.010919:0.008626:0.003407:0.005198:0.011203:0.008452:0.004608:0.010876:0.007360:0.005198:0.010220:0.011291:0.003407:0.008735:0.011203:0.010876:0.003407:0.008626:0.009478:0.008452:0.004608:0.010876:0.007360:0.005198:0.010220:0.011291:0.003407:0.008583:0.007578:0.004936:0.005875:0.008626:0.007578:0.005261:0.008932:0.003407:0.008866:0.007360:0.003407:0.009675:0.005045:0.009281:0.008626:0.011291:0.003407:0.010635:0.008539:0.004870:0.010133:0.014304:0.003407:0.014130:0.008626:0.007163:0.008626:0.003407:0.005198:0.011203:0.008452:0.004608:0.010941:0.010876:0.008735:0.010876:0.003407:0.005198:0.011948:0.004957
the study.  Sample size was calculated based on the formula   n=Z2 (1-/2) P (1-P)/d2     A descriptive correlation-:@0.070000:0.691242:0.929932:0.691242:0.929932:0.670411:0.070000:0.670411:0.006137:0.010919:0.008626:0.002402:0.007250:0.005787:0.010941:0.010723:0.007775:0.004324:0.002402:0.002402:0.009696:0.008735:0.016816:0.010635:0.004870:0.008626:0.002402:0.007360:0.005198:0.008517:0.008626:0.002402:0.014304:0.008866:0.007360:0.002402:0.008648:0.009041:0.004870:0.008733:0.011050:0.004936:0.008517:0.005875:0.008735:0.010876:0.002402:0.010548:0.008866:0.007534:0.008735:0.010876:0.002402:0.010220:0.011291:0.002402:0.006137:0.010919:0.008626:0.002402:0.005613:0.010220:0.007578:0.016816:0.011048:0.004936:0.008932:0.002402:0.002402:0.002402:0.011291:0.012011:0.012514:0.009827:0.002402:0.006901:0.009827:0.007119:0.006573:0.009827:0.006901:0.002402:0.011640:0.002402:0.006901:0.009827:0.007119:0.011640:0.006901:0.006573:0.010876:0.009827:0.002402:0.002402:0.002402:0.002402:0.002402:0.014435:0.002402:0.010876:0.008626:0.007534:0.008583:0.007578:0.004933:0.010548:0.006115:0.005045:0.009281:0.008626:0.002402:0.008583:0.010223:0.007576:0.007163:0.008539:0.004936:0.008517:0.006115:0.005198:0.010220:0.011291:0.007775
al design was adopted to carry out the present study. Data was collected using a questionnaire. The tool has 3 :@0.070000:0.709772:0.935060:0.709772:0.935060:0.688941:0.070000:0.688941:0.009041:0.004870:0.003625:0.010876:0.008626:0.007360:0.005198:0.009675:0.011291:0.003625:0.014304:0.008866:0.007360:0.003625:0.008932:0.010876:0.010242:0.010548:0.005875:0.008733:0.010876:0.003625:0.005875:0.010483:0.003625:0.008648:0.008735:0.007578:0.008080:0.009369:0.003625:0.010242:0.010677:0.006006:0.003625:0.006137:0.010919:0.008626:0.003625:0.010526:0.007163:0.008626:0.007534:0.008626:0.010876:0.006006:0.003625:0.007250:0.005787:0.010941:0.010723:0.007775:0.004324:0.003625:0.015525:0.008517:0.006137:0.008932:0.003625:0.014304:0.008866:0.007360:0.003625:0.008583:0.010330:0.004979:0.004870:0.008735:0.008733:0.005875:0.008735:0.010876:0.003625:0.010876:0.007360:0.005198:0.011116:0.009565:0.003625:0.008932:0.003625:0.010286:0.010941:0.008626:0.007250:0.006115:0.005198:0.010220:0.011291:0.011225:0.008735:0.005198:0.007163:0.008495:0.004324:0.003625:0.011695:0.010952:0.008626:0.003625:0.005875:0.010677:0.010332:0.004870:0.003625:0.010941:0.008866:0.007360:0.003625:0.010480:0.004957
sections; section I: Demographic data; section II: Disease profile and; section III medication adherence scale.:@0.070000:0.728301:0.929991:0.728301:0.929991:0.707471:0.070000:0.707471:0.007534:0.008735:0.008733:0.006115:0.005198:0.010220:0.011116:0.007360:0.004324:0.003385:0.007532:0.008735:0.008735:0.006115:0.005198:0.010220:0.011291:0.003385:0.006792:0.004324:0.003385:0.015527:0.008626:0.017143:0.010483:0.009675:0.007447:0.008515:0.010638:0.011007:0.005198:0.008583:0.003385:0.010941:0.008517:0.006137:0.008932:0.004324:0.003385:0.007534:0.008735:0.008733:0.006115:0.005198:0.010220:0.011291:0.003385:0.006792:0.006792:0.004324:0.003385:0.015396:0.005132:0.007534:0.008755:0.008866:0.007534:0.008626:0.003385:0.010524:0.007163:0.010223:0.005842:0.005294:0.004870:0.008626:0.003385:0.008735:0.011203:0.010876:0.004324:0.003385:0.007534:0.008735:0.008735:0.006113:0.005198:0.010220:0.011291:0.003385:0.006792:0.006792:0.006792:0.003385:0.017143:0.008735:0.010876:0.005198:0.008648:0.008517:0.006115:0.005198:0.010220:0.011291:0.003385:0.008932:0.010985:0.010919:0.008626:0.007163:0.008626:0.011203:0.008583:0.008626:0.003385:0.007534:0.008648:0.009041:0.004870:0.008495:0.004979
Results: :@0.070000:0.760515:0.157307:0.760515:0.157307:0.743439:0.070000:0.743439:0.014655:0.012458:0.010483:0.012902:0.005886:0.008870:0.010483:0.006249:0.005322
The total score on the adherence scale ranges from 7 to 32 with an average score of 26±4.54. It is :@0.070000:0.798144:0.908131:0.798144:0.908131:0.777314:0.070000:0.777314:0.011695:0.011607:0.009281:0.004957:0.006530:0.010897:0.006792:0.009696:0.005525:0.004957:0.008187:0.009238:0.010876:0.007818:0.009281:0.004957:0.010876:0.011946:0.004957:0.006792:0.011574:0.009281:0.004957:0.009587:0.011638:0.011574:0.009281:0.007818:0.009281:0.011858:0.009238:0.009281:0.004957:0.008189:0.009301:0.009696:0.005525:0.009281:0.004957:0.008102:0.009391:0.011771:0.010046:0.009281:0.008015:0.004957:0.006680:0.007818:0.010876:0.017886:0.004957:0.010483:0.004957:0.006530:0.011138:0.004957:0.010483:0.010483:0.004957:0.015023:0.005591:0.006792:0.011662:0.004957:0.009391:0.011946:0.004957:0.009194:0.009937:0.009281:0.008102:0.009478:0.010046:0.009281:0.004957:0.008189:0.009238:0.010876:0.007818:0.009281:0.004957:0.010876:0.006464:0.004957:0.010483:0.010483:0.012666:0.010483:0.004979:0.010483:0.010483:0.004979:0.004957:0.006593:0.006661:0.004957:0.005787:0.008015:0.004957
evident from table 4.3 that majority (43%) had moderate level of adherence. The finding shows :@0.070000:0.816674:0.896845:0.816674:0.896845:0.795843:0.070000:0.795843:0.009456:0.010177:0.005853:0.011531:0.009281:0.011529:0.006661:0.004957:0.006683:0.007818:0.010876:0.017886:0.004957:0.006792:0.009412:0.010941:0.005525:0.009281:0.004957:0.010483:0.004979:0.010483:0.004957:0.006790:0.011596:0.009172:0.006661:0.004957:0.017820:0.009172:0.005700:0.010876:0.008233:0.005591:0.006726:0.010024:0.004957:0.007556:0.010483:0.010483:0.016510:0.007556:0.004957:0.011594:0.009587:0.011531:0.004957:0.017798:0.011334:0.011531:0.009281:0.008102:0.009172:0.006530:0.009281:0.004957:0.005525:0.009456:0.009937:0.009194:0.005525:0.004957:0.010876:0.006464:0.004957:0.009587:0.011638:0.011574:0.009281:0.007818:0.009281:0.011858:0.009238:0.009150:0.004979:0.004957:0.011695:0.011607:0.009281:0.004957:0.005842:0.005842:0.011858:0.011531:0.005853:0.011771:0.010220:0.004957:0.007927:0.011574:0.010788:0.014959:0.008015:0.004957
that the sample had a mean HbA1C% of 8.4 ±1.95 which ranges from 4.9 to 17.4. Majority 46% :@0.070000:0.835204:0.901016:0.835204:0.901016:0.814373:0.070000:0.814373:0.006792:0.011596:0.009172:0.006661:0.004957:0.006792:0.011574:0.009281:0.004957:0.008144:0.009391:0.017471:0.011291:0.005525:0.009281:0.004957:0.011596:0.009587:0.011531:0.004957:0.009587:0.004957:0.017796:0.009412:0.009391:0.011946:0.004957:0.016728:0.011094:0.015090:0.010483:0.014523:0.016510:0.004957:0.010876:0.006464:0.004957:0.010483:0.004979:0.010483:0.004957:0.012666:0.010483:0.004979:0.010483:0.010483:0.004957:0.015110:0.011662:0.005853:0.009107:0.011662:0.004957:0.008102:0.009393:0.011769:0.010046:0.009281:0.008015:0.004957:0.006683:0.007818:0.010876:0.017886:0.004957:0.010483:0.004979:0.010483:0.004957:0.006528:0.011138:0.004957:0.010483:0.010483:0.004979:0.010483:0.004979:0.004957:0.019087:0.009172:0.005700:0.010876:0.008233:0.005591:0.006726:0.010024:0.004957:0.010483:0.010483:0.016510:0.004957
HbA1C% above 8. :@0.070000:0.853733:0.235469:0.853733:0.235469:0.832903:0.070000:0.832903:0.016728:0.011094:0.015090:0.010483:0.014523:0.016510:0.004957:0.009412:0.011288:0.010788:0.009937:0.009281:0.004957:0.010483:0.004979:0.004957
Conclusion: :@0.070000:0.885947:0.194722:0.885947:0.194722:0.868871:0.070000:0.868871:0.014333:0.013083:0.012881:0.011732:0.005886:0.012902:0.010483:0.005886:0.013083:0.012881:0.006249:0.005322
There is no significant prediction of disease control status by demographic variables and disease :@0.070000:0.925002:0.906580:0.925002:0.906580:0.904171:0.070000:0.904171:0.011695:0.011607:0.009281:0.007818:0.009281:0.004957:0.005787:0.008015:0.004957:0.011858:0.011138:0.004957:0.008015:0.005853:0.010327:0.011946:0.005853:0.005842:0.005842:0.009301:0.009393:0.011529:0.006661:0.004957:0.011181:0.007818:0.009391:0.011531:0.005853:0.009391:0.006768:0.005853:0.010876:0.011946:0.004957:0.010876:0.006464:0.004957:0.011531:0.005787:0.008189:0.009412:0.009522:0.008189:0.009281:0.004957:0.009238:0.010873:0.011531:0.006770:0.007818:0.010985:0.005525:0.004957:0.007906:0.006792:0.009172:0.006442:0.011531:0.008015:0.004957:0.010745:0.010024:0.004957:0.011531:0.009281:0.017796:0.011138:0.010330:0.008102:0.009172:0.011291:0.011662:0.005853:0.009238:0.004957:0.010111:0.009391:0.008231:0.005918:0.009412:0.010941:0.005525:0.009281:0.008015:0.004957:0.009391:0.011858:0.011531:0.004957:0.011531:0.005787:0.008189:0.009412:0.009522:0.008189:0.009281:0.004957
profile of the T2DM Omani patients. The hypothesis is rejected:@0.070000:0.943531:0.618948:0.943531:0.618948:0.922701:0.070000:0.922701:0.011181:0.007818:0.010876:0.005842:0.005951:0.005525:0.009281:0.004957:0.010873:0.006464:0.004957:0.006792:0.011574:0.009281:0.004957:0.013474:0.010483:0.015724:0.019458:0.004957:0.016313:0.017818:0.009391:0.011946:0.005853:0.004957:0.011553:0.009172:0.006770:0.005853:0.009281:0.011529:0.006661:0.008015:0.004979:0.004957:0.011695:0.011607:0.009281:0.004957:0.011160:0.010024:0.011640:0.010897:0.006792:0.011574:0.009281:0.008015:0.005787:0.008015:0.004957:0.005787:0.008015:0.004957:0.007818:0.009281:0.005700:0.009391:0.009388:0.006530:0.009391:0.011531
.:@0.618946:0.943104:0.623543:0.943104:0.623543:0.923876:0.618946:0.923876:0.004596